scispace - formally typeset
S

Sharon M. Rinzel

Researcher at Eli Lilly and Company

Publications -  4
Citations -  423

Sharon M. Rinzel is an academic researcher from Eli Lilly and Company. The author has contributed to research in topics: In vivo & Bicyclic molecule. The author has an hindex of 4, co-authored 4 publications receiving 413 citations.

Papers
More filters
Journal ArticleDOI

Sulfonimidamide analogs of oncolytic sulfonylureas.

TL;DR: Several sulfonimidamide analogs demonstrated excellent growth inhibitory activity in the 6C3HED model when dosed orally or intraperitoneally and a correlative structure-activity relationship to the oncolytic sulfonylureas was not apparent.
Journal ArticleDOI

Effects of diarylsulfonylurea antitumor agents on the function of mitochondria isolated from rat liver and GC3/c1 cells

TL;DR: The mechanism of antitumor activity does not appear to be the result of uncoupled as no correlation was evident between inhibition of cell growth and uncoupling action of a variety of active and inactive diarylsulfonylureas.
Journal ArticleDOI

Synthesis and biological activity of acyclic analogues of 5,10-dideaza-5,6,7,8-tetrahydrofolic acid.

TL;DR: Inhibition and cell culture reversal studies against isolated enzymes suggest the mode of action of these compounds, which were less efficient substrates for the enzyme folylpolyglutamate synthetase (FPGS) compared with their bicyclic counterparts.